Curamys
Seoul · Founded 2018
About Curamys
Curamys is a biotechnology company that develops cell fusion technology to cure intractable diseases.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2021)
- Website: http://www.curamys.com
- Phone: +82 02 766 0377
Industries & Categories
Biotechnology, Genetics, Medical
Canonical: https://fsome.com/organization/curamys-165142 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.